Bio-Techne Corporation Financials

Market Capitalization $12.22 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	80.96
Forward PE	35.12
Price to Sales TTM	$10.43
Price to Book MRQ	$5.71
Enterprise to Revenue	10.61
Enterprise to EBITDA	40.30

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2024-06-30
Most Recent Quarter	2024-09-30
Profit Margin	12.86%
Operating Margin	18.15%
Return on Assets TTM	5.55%
Return on Equity TTM	7.29%

Income Statement

Revenue TTM	$1,171,582,976
Revenue per Share TTM	$7.42
Quarterly Revenue Growth	4.50%
Gross Profit TTM	$773,937,984
EBITDA	$339,195,000
Net Income to Common TTM	$150,680,992
Diluted EPS TTM	$0.95
Quarterly Earnings Growth YoY	-34.10%

Balance Sheet

Total Cash MRQ	$187,540,000
Total Cash per Share MRQ	$1.18
Total Debt MRQ	$
Total Debt to Equity MRQ	18.65
Current Ratio MRQ	4.56
Book Value per Share MRQ	$13.46

Cash Flow

Operating Cash Flow TTM	$303,487,008
Levered Free Cash Flow TTM	$232,410,496

TECH Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	158,892,000
Float Shares	157,083,611
Avg 10 Volume	1,029,380
Avg 30 Volume	None
Shares Short	3,774,113
Short Ratio	5.42
Short % of Shares	2.72%
% Held by Insiders	1.04%
% Held by Institutions	99.53%

Stock Price Summary

Beta	1.28
Fifty Two Week Low	$61.16
Fifty Two Week High	$85.57
Fifty Two Week Change	5.54%
Day 50 MA	$74.07
Day 200 MA	$74.30

Dividends and Splits

Forward Annual Dividend Rate	$0.32
Forward Annual Dividend Yield	0.42%
Trailing Annual Dividend Rate	$0.32
Trailing Annual Dividend Yield	0.42%
Payout Ratio	33.68%
Dividend Date	2024-11-22
Ex Dividend Date	2024-11-08
Last Split Factor
Last Split Date	2022-11-30